Structural characterization and bioactivity evaluation of an acidic proteoglycan extract from Ganoderma lucidum fruiting bodies for PTP1B inhibition and anti‐diabetes

A water‐soluble PTP1B inhibitor, named FYGL‐a, was fractionated for structure investigation and bioactivity evaluation. FYGL‐a is an ingredient of a reported antihyperglycemia extract from Ganoderma Lucidum fruiting bodies. Composition analysis indicated that FYGL‐a was a 100.2 kDa acidic proteoglycan, consisting of 85 ± 2% heteropolysaccharide chain with rhamnose, galactose, glucose, and glucuronic acid residues in a mole ratio of 1.0:3.7:3.9:2.0, and the 15 ± 2% protein moiety of FYGL‐a was covalently bonded to the polysaccharide chain in O‐linkage type via threonine residues. The complete sequence of FYGL‐a was characterized systematically by periodate oxidation, Smith degradation, methylation analysis, ¹H & ¹³C 1D NMR, and 2D NMR (HSQC, HMBC, NOESY, COSY, & TOCSY). The chemical structure of FYGL‐a was determined as following, which may play special role in the competitive inhibition of PTP1B and antihyperglycemia potency. © 2013 Wiley Periodicals, Inc. Biopolymers 101: 613–623, 2014.